Events

Upcoming: 2020

February 10th - 11th, 2020

BIO CEO & Investor Conference

Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly traded and select private biotech companies. Experience the best of biotech with two days of productive partnering meetings with institutional and early-stage investors, industry analysts, and senior biotechnology executives, in one location.

Previously Attended

Biotech-Showcase-2020.png.cf.jpg
Banner-updated-10-31.jpg

January 13th - 15th, 2020

Biotech Showcase 2020

Biotech Showcase™ is an investor conference, during JPM 2020, devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year.

 

Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high quality programs that support the biotechnology and broader life sciences industry.

September 25th-28th, 2019

5th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

The Cancer Research Institute (CRI), the Association for Cancer lmmunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to present the Fifth International Cancer lmmunotherapy Conference.

The 2019 meeting will be held at the Espace Grande Arche in Paris, France from September 25 - 28, 2019. The program will focus on "Translating Science into Survival," and feature talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including: regulating T cells and their response to cancer, tumor microenvironment, genetically engineered T cells, maintenance of immune balance, novel vaccine platforms and combinations, mutational analysis and predicting response to immunotherapy, convergence of technology and cancer immunotherapy, microbiome, and metabolism. 

This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.

August 5th - 9th, 2019

7th Annual Cambridge Healthtech Institute’s Immuno-Oncology Summit

EpiVax Oncology's collaborator, Synthetic Genomics / Janssen, will be presenting their data from our joint research collaboration with Ancer selected neoantigens and RNA replicon-based personalized vaccines. Synthetic Genomics' abstract is available here: SGI/EO IO Summit Presentation.

About the IO Summit:

Join over 675 IO thought leaders at this leading annual meeting. Learn about the latest research in immuno-oncology through a comprehensive 12-track program. Network with decision makers and build lasting collaborations with an international mix of delegates. To learn more about the summit and/or to register, please visit CHI’s official event page.

May 31st, 2019

5th Annual Immuno-Oncology BD&L Investment Forum 

Taking place on the first day of ASCO, the 5th Annual Immuno-Oncology BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. Over 200 delegates and around 25 presentations by listed and private biotechnology companies seeking licensing & investment are expected.

May 20th - 23rd, 2019

TIDES: Oligonucleotide and Peptide Therapeutics 

The world’s largest meeting to accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

May 14th - 15th, 2019

Frontiers in Cancer Immunotherapy

This two-day symposium convenes leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies. Particular emphasis will be given to the biological mechanisms underlying combination hypotheses, bispecific antibodies and other emerging modalities for delivery of combination therapies, as well as a discussion of the importance of biomarkers and effective clinical trial design.

March 29th - April 3rd, 2019

AACR 2019 Annual Meeting

The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world. 

EpiVax Oncology's abstract was selected for an oral presentation at the American Association for Cancer Research conference in Atlanta, on March 31st, 3 P.M - 5 P.M. Our Lead Computational Immunologist, Guilhem Richard presented: Filtering out Self-Like Neoantigens Improves Immune Response To Cancer Vaccines.

 

Click here for the presentation's slides

Click here to access AACR's video recording of the presentation (available to conference attendants via webcast.aacr.org).

February 11th - 12th, 2020

BIO CEO & Investor Confernce 2019

Now in its 21st year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

January 7th - 9th, 2020

Biotech Showcase 2019

Biotech Showcase™ is an investor conference, during JPM 2019, devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year.

November 7th - 11th, 2018

SITC's 33rd Annual Meeting

The Society for Immunotherapy of Cancer's (SITC) 33rd Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy.

The Annual Meeting (View Schedule Online or Download a PDF) consisted of cutting-edge research presentations by experts in the field, both oral and poster abstract presentations, and ample opportunity for structured and informal discussions, including important networking opportunities. In addition, the meeting included updates on major national and international initiatives coming from academia, government and industry, as well as important society projects.

June 4th - 7th, 2018

2018 BIO International Convention

The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. 

February 12th - 13th, 2018

SITC's 33rd Annual Meeting

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, BIO One-on-One Partnering meetings, and networking opportunities.

© Copyright Epivax Oncology 2020